Skip to main content
All lobbying filings

OGR

OGR filed a Q1 report for AMGEN USA INC on April 19, 2026, reporting $50,000 in lobbying income.

Lobbying for AMGEN USA INC

All filings by OGR · Everything AMGEN USA INC has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 19, 2026
Income
$50,000
What the client paid this registrant for the period.

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Issues related to Medicare Part D and Medicare Part B reimbursement and coverage. Issues related to drug pricing. Issues related to biosimilar regulation. Issues related to 340B reform.

Taxation/Internal Revenue Code

Issues related to Puerto Rico.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem